|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 338.66 USD | +2.31% |
|
+2.98% | +3.50% |
| Jan. 20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| Jan. 15 | Espiria Hållbar Framtid Rises 0.4 Percent in December — Increased Holdings in Epiroc and Afry | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AMGN Stock
- Consensus Amgen Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
